Intra Cellular Therapies shares owned by Kennedy Capital Management
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Kennedy Capital Management
from 13F filings
Historical chart of Kennedy Capital Management investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Kennedy Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Kennedy Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $768k | 5.8k | 131.92 |
| 2024-12-31 | $480k | 5.7k | 83.52 |
| 2024-09-30 | $343k | 4.7k | 73.17 |
| 2024-06-30 | $245k | 3.6k | 68.49 |
| 2024-03-31 | $1.3M | 19k | 69.20 |
| 2023-12-31 | $2.0M | 27k | 71.62 |
| 2023-09-30 | $1.6M | 30k | 52.09 |
| 2023-06-30 | $4.4M | 70k | 63.32 |
| 2023-03-31 | $5.9M | 108k | 54.15 |
| 2022-12-31 | $16M | 309k | 52.92 |
| 2022-09-30 | $15M | 324k | 46.53 |
| 2022-06-30 | $15M | 253k | 57.08 |
| 2022-03-31 | $15M | 241k | 61.19 |
| 2021-12-31 | $11M | 205k | 52.34 |
| 2021-09-30 | $3.7M | 98k | 37.28 |
More positions owned by Kennedy Capital Management
View all positions for Kennedy Capital Management
Top funds holding Intra Cellular Therapies
View all funds holding Intra Cellular Therapies